Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback